CoChat

A Novel in Vivo Rabbit Model of Hypercatabolic Critical Illness Reveals a Biphasic Neuroendocrine Stress Response

Frank Weekers, Erik Van Herck, Willy Coopmans, Marina A. Michalaki, Cyril Y. Bowers, Johannes D. Veldhuis, Greet Van den Berghe · 2002 · Endocrinology
Cited by 78

The DOI matches its OpenAlex record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

High doses of GH, used to induce anabolism in prolonged critically ill patients, unexpectedly increased mortality. To further explore underlying mechanisms, a valid animal model is needed. Such a model is presented in this study. Seven days after arterial and venous cannulae placement, male New Zealand White rabbits were randomly allocated to a control or a critically ill group. To induce prolonged critical illness, a template controlled 15% deep dermal burn injury was imposed under combined general and regional (paravertebral) anesthesia. Subsequently, critically ill rabbits received supplemental analgesia and were parenterally fed with glucose, insulin, amino acids, and lipids. On d 1 and d 8 after randomization, acute and chronic spontaneous hormonal profiles of GH, TSH, and PRL secretion were obtained by sampling blood every 15 min for 7 h. Furthermore, GH, TSH, and PRL responses to an iv bolus of GH-releasing peptide 2 (GHRP-2) + TRH were documented on d 0, 1, and 8. Hemodynamic status and biochemical parameters were evaluated on d 0, 1, 3, 5, and 8, after which animals were killed and relative wet weight and water content of organs was determined. Compared with controls, critically ill animals exhibited transient metabolic acidosis on d 1 and weight loss, organ wasting, systolic hypertension, and pronounced anemia on d 8. On d 1, pulsatile GH secretion doubled in the critically ill animals compared with controls, and decreased again on d 8 in the presence of low plasma IGF-I concentrations from d 1 to d 8. GH responses to GHRP-2 + TRH were elevated on d 1 and increased further on d 8 in the critically ill animals. Mean TSH concentrations were identical in both groups on d 1 and 8, in the face of dramatically suppressed plasma T(4) and T(3) concentrations in the critically ill animals. PRL secretion was impaired in the critically ill animals exclusively on d 8. TSH and PRL responses to GHRP-2 and TRH were increased only on d 1. In conclusion, this rabbit model of acute and prolonged critical illness reveals several of the clinical, biochemical, and endocrine manifestations of the human counterpart.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

OpenAlex · 10.1210/en.143.3.764

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 37

  1. Streat, 1987, Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients., J Trauma, 27, 262, 10.1097/00005373-198703000-00006 · DOI · Paper page
  2. Van den Berghe, 1997, The somatotropic axis in critical illness: effect of continuous growth hormone releasing hormone and GH releasing peptide-2 infusion., J Clin Endocrinol Metab, 82, 590
  3. Van den Berghe, 1998, Acute and prolonged critical illness as different neuroendocrine paradigms., J Clin Endocrinol Metab, 83, 1827
  4. Rivier, 1985, Involvement of corticotropin-releasing factor in ether stress inhibition of growth hormone secretion in the rat., Endocrinology, 117, 2478, 10.1210/endo-117-6-2478 · DOI · Paper page
  5. Ramsden, 1979, Effects of surgical stress and corticotrophin on the peripheral metabolism of thyroid hormones in rabbits., J Endocr, 82, 403, 10.1677/joe.0.0820403 · doi:10.1677/joe.0.0820403
  6. McIntyre H and Odell, 1974, Physiological control of growth hormone in the rabbit., Neuroendocrinology, 16, 8, 10.1159/000122548 · DOI
  7. Hu, 1998, A rabbit model for metabolic studies after burn injury., J Surg Res, 75, 153, 10.1006/jsre.1998.5274 · DOI
  8. Van den Berghe, 2000, A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness., J Clin Endocrinol Metab, 85, 183
  9. Van den Berghe, 1999, Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness., J Clin Endocrinol Metab, 84, 1311
  10. Verhaeghe, 1992, The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats., J Endocrinol, 134, 485, 10.1677/joe.0.1340485 · DOI
  11. Veldhuis, 1987, The pituitary gland secretes in bursts: appraising the nature of glandular secretary impulses by simultanuous multiple parameter deconvolution of plasma hormone concentrations., Proc Natl Acad Sci USA, 84, 7686, 10.1073/pnas.84.21.7686 · DOI · Paper page
  12. Imbimbo, 1994, Growth hormone releasing activity of hexarelin in humans: a dose response study., Eur J Clin Pharm, 46, 421, 10.1007/BF00191904 · DOI
  13. Van den Berghe, 1996, Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotropin-releasing hormone in critical illness., Clin Endocrinol, 45, 341, 10.1046/j.1365-2265.1996.00805.x · DOI · Paper page
  14. Elias, 1995, In vitro characterization of four novel classes of growth hormone-releasing peptide., Endocrinology, 136, 5694, 10.1210/endo.136.12.7588325 · doi:10.1210/endo.136.12.7588325 · Paper page
  15. Carmignac, 1998, Effects of growth hormone secretagogues on prolactin release in anesthetized dwarf (dw/dw) rats., Endocrinology, 139, 3590, 10.1210/endo.139.8.6148 · DOI
  16. Michelsen, 1982, Effect of an anabolic steroid on nitrogen balance and amino acid patterns after total hip replacement., J Trauma, 22, 410, 10.1097/00005373-198205000-00011 · doi:10.1097/00005373-198205000-00011
  17. Wallner, 1986, The anemia of thermal injury: mechanism of inhibition of erythropoiesis., Proc Soc Exp Biol Med, 181, 144, 10.3181/00379727-181-42236 · doi:10.3181/00379727-181-42236
  18. Carlson, 1987, Fluid retention and burn survival., J Trauma, 27, 127, 10.1097/00005373-198702000-00005 · doi:10.1097/00005373-198702000-00005
  19. Lawrence C and Atac, 1992, Hematologic changes in massive burn injury., Crit Care Med, 20, 1284, 10.1097/00003246-199209000-00015 · doi:10.1097/00003246-199209000-00015
  20. Wojnar, 1995, Alterations in the insulin like growth factor system in trauma patients, Am J Physiol, 268, R970
  21. Ross, 1991, Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I., Clin Endocrinol Oxf, 35, 47, 10.1111/j.1365-2265.1991.tb03495.x · DOI · Paper page
  22. Hartman, 1991, Temporal structure of in vivo growth hormone secretory events in humans, Am J Physiol, 260, E101
  23. Kojima, 1999, Ghrelin is a growth-hormone-releasing acylated peptide from stomach., Nature, 402, 656, 10.1038/45230 · DOI · Paper page
  24. Jaffe, 1993, Effects of a prolonged growth hormone-releasing peptide infusion on pulsatile GH secretion in normal men., J Clin Endocrinol Metab, 77, 1641
  25. Bowers, 2001, Unnatural growth hormone-releasing peptide begets natural ghrelin., J Clin Endocrinol Metab, 86, 1464, 10.1210/jcem.86.4.7431 · doi:10.1210/jcem.86.4.7431 · Paper page
  26. Pandya, 1998, Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation., J Clin Endocrinol Metab, 83, 1186
  27. Maheshwari, 1999, Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency., J Clin Endocrinol Metab, 84, 956
  28. Veldhuis, 2001, Lowering total plasma IGF-I concentrations by way of a novel, potent and selective GH-receptor antagonist, pegvisomant (B2036-PEG), augments the amplitude of GH secretory bursts and elevates basal nonpulsatile GH release in healthy women and men., J Clin Endocrinol Metab, 86, 3304
  29. Van den Berghe, 1998, Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin releasing hormone and its combination with growth hormone secretagogues., J Clin Endocrinol Metab, 83, 309
  30. Challa, 1993, Metabolic acidosis inhibits growth hormone secretion in the rat, Mechanisms of growth retardation. Am J Physiol, 265, E547
  31. Corsi, 1997, Effects of acute and chronic inflammation on plasma growth hormone levels in rats., Drugs Exp Clin Res, 23, 117
  32. Utiger, 1980, Decreased extrathyroidal triiodothyronine production in non thyroidal illness: benefit or harm?, Am J Med, 132, 144
  33. Phillips, 1984, Circulating thyroid hormone changes in acute trauma: prognostic implications for clinical outcome., J Trauma, 24, 116, 10.1097/00005373-198402000-00004 · DOI · Paper page
  34. Leon Sanz, 1997, Pituitary-thyroid function in patients with septic shock and its relation with outcome., Eur J Med Res, 28, 477
  35. Tache, 1976, Shift in adenohypophyseal activity during chronic intermittent immobilization of rats., Neuroendocrinology, 22, 325, 10.1159/000122641 · DOI · Paper page
  36. Viquerat, 1985, Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities., Am J Med, 78, 455, 10.1016/0002-9343(85)90338-9 · DOI
  37. Van den Berghe, 1999, Growth hormone releasing peptide-2 infusion synchronizes growth hormone, thyrotropin and prolactin release in prolonged critical illness., Eur J Endocrinol, 140, 17, 10.1530/eje.0.1400017 · DOI · Paper page

Cited by

See all 78

Metadata

Authors
Weekers, F., Herck, E. V., Coopmans, W., Michalaki, M. A., Bowers, C. Y., Veldhuis, J. D., & den Berghe, G. V.
Venue
Endocrinology
Published
2002-03-01
Volume
143
Issue
3
Pages
764-774
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2033155942
Cited by
78
References
7
FWCI
2.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Novel in Vivo Rabbit Model of Hypercatabolic Critical Illness Reveals a Biphasic Neuroendocrine Stress Response. https://app.cochat.ai/papers/10.1210/en.143.3.764
The paper
Weekers, F., Herck, E. V., Coopmans, W., Michalaki, M. A., Bowers, C. Y., Veldhuis, J. D., & den Berghe, G. V. (2002). A Novel in Vivo Rabbit Model of Hypercatabolic Critical Illness Reveals a Biphasic Neuroendocrine Stress Response. Endocrinology. https://doi.org/10.1210/en.143.3.764

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.